Rapamycin Enhances CAR-T Control of HIV Replication and Reservoir Elimination in vivo

By sjmartinez • February 12, 2025

Mu W, Tomer S, Harding J, Kedia N, Rezek V, Cook E, Patankar V, Carrillo MA, Martin H, Ng HL, Wang L, Marsden MD, Kitchen SD, Zhen A. Rapamycin Enhances CAR-T Control of HIV Replication and Reservoir Elimination in vivo. J Clin Invest. 2025 Feb 11:e185489. doi: 10.1172/JCI185489. Epub ahead of print. PMID: 39932788.

Tags: AIDS/HIV, Hematology/Oncology, Immunology, immunotherapy, Post Doc, Publications, T cells

Favezelimab plus pembrolizumab for anti-PD-1-refractory classic Hodgkin lymphoma: an open-label phase 1/2 study

Timmerman J, Lavie D, Johnson NA, Avigdor A, Borchmann P, Andreadis C, Bazargan A, Gregory GP, Keane C, Tzoran I, Vucinic V, Zinzani PL, West[...]

A Phase 1 Study of PF-07062119, an Anti-GUCY2C/Anti-CD3 Bispecific Fc Antibody, in Patients With Advanced Gastrointestinal Cancers

Fakih M, Doi T, Tolcher A, Hong D, Tie J, Messersmith W, Koyama T, Rosen L, Borlido J, Damore MA, Delioukina M, Cheronis I, Clark[...]

Demystifying financial toxicity measures: semi-structured interviews comparing COST-FACIT and ENRICh among cancer survivors on targeted oral anticancer medications (TOAMs)

Lowenstein LM, Bernal MP, Bergren EP, Busaidy TK, Brauer ER, Ganz PA, Smith GL, Shih YT. Demystifying financial toxicity measures: semi-structured interviews comparing COST-FACIT and[...]